Patent Injunction Sustained Against Canva’s Presentation Recording Tool
The Delhi High Court refused to interfere with an interim injunction restraining Canva from offering its “Present and Record” feature in India. The Court found a prima facie case of patent infringement and held that allowing commercial use at this stage would undermine patent enforcement pending final adjudication.
Madras High Court Grants Pre-Release Anti-Piracy Protection to Feature Film
The Madras High Court issued an ad-interim injunction preventing unauthorised broadcast and dissemination of the film Mardaani 3. Recognising the high risk of digital piracy, the Court held that preventive relief was necessary to protect copyright interests before the film’s public release.
Descriptive Use of ‘Vapo’ Placed in Public Domain by Madras High Court
The Madras High Court held that the term “Vapo” is descriptive and generic, rejecting claims of exclusive trademark rights. The Court observed that granting monopoly over commonly used expressions would distort market competition and exceed the protection contemplated under trademark law.
Procedural Lapses Lead to Revival of Long-Standing Spice Trademark
Setting aside the Trademark Registry’s cancellation order, the Madras High Court reinstated the Sakthi Masala mark. The Court held that cancellation without adequate notice and opportunity of hearing violated statutory safeguards and could not extinguish vested trademark rights.
Court Restrains Impersonation and Misuse of Delhivery’s Brand Assets
The Delhi High Court granted interim relief to Delhivery, restraining unknown parties from misusing its trademarks and copyrighted material. The Court noted that digital impersonation and deceptive conduct justified urgent injunctive protection to prevent consumer confusion and reputational damage.
Delhi High Court Orders Takedown of Counterfeit ‘Happi Planet’ Listings
The Delhi High Court granted an ex-parte injunction against counterfeit Happi Planet products sold online, directing e-commerce platforms to remove infringing listings and disable rogue sellers. The Court held that unchecked counterfeiting causes irreparable harm to brand goodwill and consumer trust, warranting immediate judicial intervention.
California Senate Moves to Regulate Lawyers’ Use of AI
The California Senate passed a bill on AI use in legal practice, requiring attorneys to verify accuracy of AI-generated work before court filings and barring arbitrators from relying on undisclosed AI reasoning. The legislation mandates steps to mitigate bias and protect confidentiality, aiming to curb “hallucinations” and align AI use with ethical and procedural responsibilities.
Deezer Licenses AI Detection Tool to French Rights Agency Sacem
Deezer has licensed its AI-based music detection technology to France’s Sacem to tackle streaming fraud from AI-generated tracks. The tool, trained on millions of songs, flags and removes fraudulent uploads, reflecting a broader push to protect royalty integrity as generative AI blurs lines between human and machine-created music.
Anthropic Faces Escalated Copyright Lawsuit by Major Music Publishers
Anthropic is defending a new copyright infringement suit in California federal court brought by major music publishers including Universal and Concord, alleging the AI company pirated over 20,000 songs to train its Claude model. Plaintiffs seek damages potentially exceeding $3 billion, intensifying legal scrutiny over AI training data practices.
App Developer Sues Apple for Antitrust, Alleged Theft of Camera Tech
A mobile video app maker filed suit in New Jersey federal court accusing Apple of incorporating its patented technology into Apple’s Continuity Camera feature and violating U.S. antitrust law by leveraging ecosystem control to suppress competition. The case combines patent and competition claims, seeking remedies for alleged misappropriation and unlawful market conduct.
Boehringer Ingelheim Licenses Chinese IBD Drug Candidate from Simcere
German pharma company Boehringer Ingelheim entered a licensing agreement with China’s Simcere Pharmaceutical for a pre-clinical inflammatory bowel disease therapy, paying upfront funds and potential milestone payments. The deal grants Boehringer global rights outside China, strengthening its autoimmune pipeline and underscoring cross-border R&D collaboration in biopharmaceutical innovation.
Meta and EssilorLuxottica Hit With Smartglasses Technology Lawsuit
Meta and partner EssilorLuxottica are being sued in the U.S. over alleged infringement of smart glasses patents. The suit targets core technologies underlying wearable devices and seeks damages and injunctive relief, suggesting growing legal friction in the intersection of AI, wearable tech, and intellectual property rights.
